Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 27Lymphoma, Non-Hodgkin 25Lymphoma 20Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Leukemia 20Hodgkin Disease 14Central Nervous System Neoplasms 13Breast Neoplasms 13Hematologic Neoplasms 12Leukemia, Lymphocytic, Chronic, B-Cell 11Neuroblastoma 9Burkitt Lymphoma 9Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Myeloproliferative Disorders 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Biphenotypic, Acute 7Lymphoma, Follicular 6Graft vs Host Disease 6Dendritic Cell Sarcoma, Interdigitating 6Congenital Abnormalities 6Brain Neoplasms 6Blast Crisis 6Anemia, Refractory, with Excess of Blasts 6Testicular Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, B-Cell, Marginal Zone 5

Interventions

Amifostine 10Cisplatin 8Radiotherapy 7Etoposide 6Cyclophosphamide 4Carboplatin 4Paclitaxel 3pegfilgrastim 2camrelizumab 2apatinib 2Mitoxantrone 2Filgrastim 2Drug Therapy 2Cytarabine 2sodium thiosulfate 1sargramostim 1pazopanib 1icotinib 1glucarpidase 1etoposide phosphate 1denileukin diftitox 1Vitamin E 1Triptorelin Pamoate 1Tocopherols 1Thiotepa 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Silymarin 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Drug-Related Side Effects and Adverse Reactions × Thiotepa × Clear all
NCT00003068 2013-01-31

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡